David Chaplin

David J.
Chaplin currently works at Phusis Therapeutics, Inc., as Director from 2012 and Fast BioPharma Ltd., as Non-Executive Director from 2017.
Dr. Chaplin also formerly worked at Oncotelic Therapeutics, Inc., as Executive Vice Chairman & Chief Scientific Officer from 2000 to 2011, Oncotelic Therapeutics, Inc., as Director & Chief Scientific Officer from 2018 to 2019, Rhone Poulenc Rorer, as Senior Director-Oncology from 1998 to 1999, Aston Biopharma Ltd., as Director, Smart Matrix Ltd., as Director, Xenova Group Plc, as Section Head-Cancer Biology from 1990 to 1992, Aventis Pharma SARL, as Vice President-Oncology from 1999 to 2000, and The Cancer Research Campaign, as Head-Tumor Microcirculation Group from 1992 to 1998.
Dr. Chaplin received his graduate degree from The University of Southampton, doctorate degree from the University of London, and undergraduate degree from the University of Essex.